SCHEMBL2954623

SCHEMBL2954623

CC1=C(C/C=C/C=O)C(C)(C)CC=C1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.32
MAOB P27338 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6688550 0.83 MAOA (0.35) MAOAMAOB
SCHEMBL5666337 0.81 MAOA (0.37) MAOAMAOB
SCHEMBL25204194 0.75 MAOA (0.33) MAOAMAOB
SCHEMBL11654626 0.73 MAOA (0.33) MAOAMAOB
SCHEMBL5435984 0.71 MAOA (0.35) MAOAMAOB
SCHEMBL12309700 0.70 MAOA (0.37) MAOAMAOB
SCHEMBL11646545 0.69 MAOA (0.33) MAOAMAOB
SCHEMBL31121665 0.69 MAOA (0.33) MAOAMAOB
SCHEMBL31546116 0.68
SCHEMBL11433225 0.68 MAOA (0.33) MAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019193024-A1 IMPROVEMENTS IN OR RELATING TO A PERFUME COMPOSITION FOR USE IN AN AIR FRESHENER DEVICE GIVAUDAN SA (CH) 2019-10-10 WO disclosed
US-8865634-B2 4-alkyl substituted pyridines as odiferous substances SYMRISE AG (DE) 2014-10-21 US disclosed
US-20100130624-A1 4-ALKYL SUBSTITUTED PYRIDINES AS ODIFEROUS SUBSTANCES SYMRISE GMBH & CO. KG (DE) 2010-05-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100130624-A1 4-ALKYL SUBSTITUTED PYRIDINES AS ODIFEROUS SUBSTANCES CYP4A22, CYP4X1, CYP4B1 MAOA 517/4885MAOB 284/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.